Myriad Genetics Inc (MYGN) Event Aug. 04, 2022, 11:06 UTC 15 1 comments (10% Negative) MYRIAD GENETICS, INC. (MYGN) Reports Q3 2022 Financial Results Comment Full text
BioCryst Pharmaceuticals Inc (BCRX) Event Aug. 04, 2022, 11:06 UTC 14 1 comments (10% Negative) BioCryst Pharmaceuticals, Inc. (BCRX) Reports Q3 2022 Financial Results Comment Full text
Travere Therapeutics, Inc (TVTX) Event Aug. 04, 2022, 11:06 UTC 15 1 comments (10% Negative) TRAVERE THERAPEUTICS, INC. (TVTX) Reports Q3 2022 Financial Results Comment Full text
Bicycle Therapeutics (BCYC) Event Aug. 04, 2022, 11:03 UTC 15 1 comments (10% Negative) Bicycle Therapeutics plc (BCYC) Reports Q3 2022 Financial Results Comment Full text
COMPASS Pathways plc (CMPS) Event Aug. 04, 2022, 11:02 UTC 15 1 comments (10% Negative) COMPASS PATHWAYS PLC (CMPS) Reports Q3 2022 Financial Results Comment Full text
Amicus Therapeutics Inc (FOLD) Event Aug. 04, 2022, 11:01 UTC 13 1 comments (10% Negative) AMICUS THERAPEUTICS, INC. (FOLD) Reports Q3 2022 Financial Results Comment Full text
Harvard Bioscience Inc (HBIO) Event Aug. 04, 2022, 11:01 UTC 13 1 comments (97% Positive) HARVARD BIOSCIENCE, INC. (HBIO) Reports Q3 2022 Financial Results Comment Full text
Compugen Ltd (CGEN) Event Aug. 04, 2022, 11:00 UTC 10 1 comments (30% Negative) Compugen Ltd (CGEN) Reports Q2 2022 Financial Results (Form 6-K) Comment Full text
Immunic Inc (IMUX) Event Aug. 04, 2022, 10:45 UTC 13 1 comments (70% Positive) IMMUNIC, INC. (IMUX) Reports Q3 2022 Financial Results Comment Full text
SpringWorks Therapeutics (SWTX) Event Aug. 04, 2022, 10:41 UTC 13 1 comments (10% Negative) SPRINGWORKS THERAPEUTICS, INC. (SWTX) Announces Delay in results Trials for multiple myeloma Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review Comment Full text